A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
Clinical trial NCT02973100 · COMPLETED
Trial details
- NCT number
- NCT02973100
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-07-15
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.